| Identifier |
20190319_nanos_newinfo_1_04-abstract |
| Title |
New Treatments for Multiple Sclerosis |
| Creator |
Sashank Prasad, MD |
| Subject |
Multiple Sclerosis; Rituximab; Alemtuzumab; Siponimod; Ocrelizumab |
| Description |
The era of disease modifying therapy for Multiple Sclerosis (MS), which began with ACTH in the 1950s, has truly accelerated in the past 2 decades. Neuro-ophthalmologists should be aware of the important recent therapeutic advances that will impact their patients with MS. |
| Date |
2019-03 |
| Language |
eng |
| Format |
application/pdf |
| Source |
2019 North American Neuro-Ophthalmology Society Annual Meeting |
| Relation is Part of |
NANOS 2019: New Information I Should Know |
| Collection |
Neuro-ophthalmology Virtual Education Library: NOVEL http://NOVEL.utah.edu |
| Publisher |
Spencer S. Eccles Health Sciences Library, University of Utah |
| Holding Institution |
North American Neuro-Ophthalmology Association. NANOS Executive Office 5841 Cedar Lake Road, Suite 204, Minneapolis, MN 55416 |
| Rights Management |
Copyright 2019. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright |
| ARK |
ark:/87278/s6mh24b5 |
| Context URL |
The NANOS Annual Meeting Neuro-Ophthalmology Collection: https://novel.utah.edu/collection/NAM/toc/ |
| Contributor Primary |
Sashank Prasad, MD |
| Setname |
ehsl_novel_nam |
| ID |
1423178 |
| Reference URL |
https://collections.lib.utah.edu/ark:/87278/s6mh24b5 |
